Research direction
Therapy Workflow Research
Research into therapy workflows requires careful definitions of observations, time points, and comparison methods. OraDigit explores how that context could be organized for transparent research review.
Who this is for: Nuclear-medicine researchers, imaging teams, and collaborators defining a governed longitudinal-study question.
Frame a research question before modeling outcomes
A collaboration could investigate the following, after agreeing on scope, access boundaries, and evaluation criteria:
- Describe which observations and time points a research comparison would need.
- Explore synthetic representations of imaging and workflow context, with explicit provenance and missing-data handling.
- Define comparators, review responsibilities, and evidence requirements for any future study.
Current scope and limits
This research direction does not predict patient response, recurrence, or toxicity, plan dosimetry, select therapy, or personalize treatment. Clinical interpretation and care remain the responsibility of qualified professionals.
Implementation requires project-specific scope, privacy and security review, and approval. No clinical validation, measured benefit, regulatory approval, or customer adoption is established here.
PET Response Tracker — Research prototype explores baseline and follow-up organization. It does not establish treatment-response prediction.
Start with a bounded conversation
Describe the workflow or research question, intended users, and constraints. We can discuss what needs investigation before any implementation commitment.
Do not send patient information, protected health information, credentials, or confidential organizational data.
Contact OraDigit